Zynerba Pharmaceuticals logo
Zynerba Pharmaceuticals ZYNE
$ 1.3 0.0%

Quarterly report 2023-Q2
added 08-14-2023

report update icon

Zynerba Pharmaceuticals Depreciation & Amortization 2011-2024 | ZYNE

Annual Depreciation & Amortization Zynerba Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
219 K 247 K 207 K 134 K 99.6 K 94.2 K 75.3 K 26 K 27.1 K 49.4 K - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
247 K 26 K 118 K

Quarterly Depreciation & Amortization Zynerba Pharmaceuticals

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 51.6 K - 166 K 115 K 60.7 K - 185 K 123 K 61.5 K - 57.8 K 48.2 K 41.2 K - 36 K 32.9 K 29.3 K - 25 K 21.6 K 26.6 K - 24.8 K 23.2 K 20.4 K - 25.8 K 13.9 K 13.6 K - 8.23 K 3.1 K 1.45 K - 6.85 K 9.13 K - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
185 K 1.45 K 45.6 K